Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-748-4 | CAS number: 95009-22-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- No data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Multi-centre comparative study based on OECD Guidelines; not all variables controlled. Reasonably well-reported publication. Study carried out with caffeine, a key component of cocoa.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 004
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- GLP compliance:
- yes
- Remarks:
- Two/10 participating laboratories were GLP-compliant, the others (n=8) “adhered to this quality system as much as possible”.
Test material
- Reference substance name:
- 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
- IUPAC Name:
- 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
- Reference substance name:
- Caffeine
- EC Number:
- 200-362-1
- EC Name:
- Caffeine
- Cas Number:
- 58-08-2
- Molecular formula:
- C8H10N4O2
- IUPAC Name:
- 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione
- Reference substance name:
- 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-
- EC Number:
- 619-173-4
- IUPAC Name:
- 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-
- Details on test material:
- - Name of test material (as cited in study report): Caffeine
- Molecular formula (if other than submission substance): C8H10N4O2
- Molecular weight (if other than submission substance): 194.2
- Smiles notation (if other than submission substance): c12c(n(=O)n(c1=O)C)C)ncn2C
- InChl (if other than submission substance): 1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
- Structural formula attached as image file (if other than submission substance): see Fig. 1
- Substance type:
- Physical state: solid
- Analytical purity: no data
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: no data
- Isomers composition: no data
- Purity test date: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Radiochemical purity (if radiolabelling): no data
- Specific activity (if radiolabelling): 51.2 mCi/mmol
- Locations of the label (if radiolabelling): 1-methyl-14C
- Expiration date of radiochemical substance (if radiolabelling): no data
- Stability under test conditions: no data
- Storage condition of test material: no data
Constituent 1
Constituent 2
Constituent 3
- Radiolabelling:
- yes
- Remarks:
- In 7 cases
Test animals
- Species:
- human
- Strain:
- other: Not applicable
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No data
Administration / exposure
- Type of coverage:
- other: Not applicable
- Vehicle:
- other: ethanol:water, 1:1 v/v
- Duration of exposure:
- 24 hours
- Doses:
- 4 mg/ml concentration: application of 25 µL/cm2 skin surface, therefore 100 µg/cm2 [0.32-3.14 cm2 exposed]
- Control animals:
- no
- Remarks:
- Not applicable
- Details on study design:
- No data
- Details on in vitro test system (if applicable):
- SKIN PREPARATION
- Source of skin: surgical waste/post-mortem
- Ethical approval if human skin: in accordance with national guidelines
- Type of skin: full thickness/dermatomed from breast, leg or abdomen
- Preparative technique: cleaned of subcutaneous fat
- Thickness of skin (in mm): 0.3 – 1.8
- Membrane integrity check: visual/tritiated water/capacitance
- Storage conditions: -20oC (-70oC for 2 participants)
- Justification of species, anatomical site and preparative technique: to study robustness of methodology
PRINCIPLES OF ASSAY
- Diffusion cell: static (4 labs) and flow-through (6-labs)
- Receptor fluid: saline (0.9% NaCl)
- Solubility of test substance in receptor fluid: no data
- Static system: receptor compartment volume 5.0 – 17.7 ml with stirrer bar
- Flow-through system: receptor compartment volume 0.25 – 3.5 ml with/without stirrer bar; flow rate approx 1.5 ml/h
- Test temperature: no data
- Humidity: no data
- Occlusion: yes
- Reference substance(s): not applicable
- Other: Exposed skin area 0.64 – 3.14 cm2 (static cells); 0.32 – 0.95 cm2 (flow-through).
12-22 replicates/laboratory (9 labs).
Repeated sampling of receptor fluid, at a minimum of 1,2,4,8 and 24-hours. Test material remaining at 24-hr was removed with cotton swabs (5) soaked in EtOh/H20 (1:1, v/v) and a dry cotton swab.
Results and discussion
- Signs and symptoms of toxicity:
- not specified
- Remarks:
- Not applicable
- Dermal irritation:
- not specified
- Remarks:
- Not applicable
- Total recovery:
- Human skin at 24h – 24.5 ± 11.6 % dose (9 participants)
Rat skin at 24h – 53.7 ± 2.9 % dose (1 participant)
Human skin at 24h – 66.4 – 100.6 % dose (6 participants)
Rat skin at 24 h – 99.5 ± 0.2 % dose (1 participant)
Any other information on results incl. tables
Percutaneous absorption rate
Time point:
Max. absorption rate : 1.2 – 5.2 h (Human)
Rate:
Mean max. rate : 2.24±1.43µg/cm2/h
Percutaneous absorption rate[multiple blocks possible]
Time point:
Max absorption rate : 1.2± 0.2 h (Rat)
Rate:
Mean max. rate : 6.82±0.82µg/cm2/h
Remarks:
Percutaneous absorption rate[multiple blocks possible]
Time point:
24 h
Dose:
4 mg/ml
Absorption (%):
> |
13 |
< |
45 |
Remarks:
For human skin, total penetration was determined to be 13.1 to 44.5% (in 6 labs)
Percutaneous absorption rate[multiple blocks possible]
Time point:
24 h
Dose:
4 mg/ml
Absorption (%):
ca |
61 |
|
|
Remarks:
For rats, total penetration was determined to be about 61.3% (in 1 lab)
Applicant's summary and conclusion
- Conclusions:
- In a multi-centre comparative in vitro skin absorption study, the total penetration in 24-hr of caffeine across human skin was calculated to be about 13-45%, whilst rat skin was about 61%.
- Executive summary:
In a study to investigate the robustness of in vitro percutaneous absorption methodology, the rate of absorption of caffeine through human and rat skin preparations was determined by 10 participating laboratories and the extent of absorption by 7 laboratories. Experiments with human skin preparations were carried out to a common protocol based on OECD Guideline 428, using preparations derived from stored post-mortem or surgical waste samples from both male and female subjects. Skin samples varied in thickness from 0.3 to 1.8 mm and were used in either static or flow-through cells. Full-thickness rat skin preparation from young male Sprague-Dawley rats were also used. Caffeine was applied at a dose of 100µg/cm2and levels determined in receptor fluid at intervals up to 24 hr. After washing, the residual levels in skin were also determined.
The maximum rate of percutaneous absorption of caffeine through human skin was about 2.2µg/cm2/hr and through rat skin was about 6.8µg/cm2/hr and the time to maximum absorption was between 1.2-5.2 hr in humans and about 1.2 hr in rats. Recovery in receptor fluid at 24 hr amounted to about 25% of the dose for human skin and 54% for rat skin and mean recovery in the washed skin at 24 hr varied from 1 to 12% of the dose for human skin and about 8% for rat skin. Overall recovery of the applied dose varied from 66 to 100% for human skin and 99.5% for rat skin.
In conclusion, the total penetration in 24-hr of caffeine across human skin was calculated to be about 13-45%, whilst rat skin was about 61%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.